Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk G Bechara

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
Archives of Dermatological Research|June 22, 2017
The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesionsS Hessam, M Sand, M Skrygan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 19, 2013
Penetrating defect of the ala nasi: combined reconstruction with a myocutaneous hinge- and paramedian forehead flapSchapoor Hessam, Dimitrios Georgas, Michael Sand, et al.
Dermatology and Therapy|January 10, 2023
Hyperhidrosis: A Central Nervous Dysfunction of Sweat SecretionJohannes Wohlrab, Falk G Bechara, Christoph Schick, et al.
Cancer Biomarkers : Section a of Disease Markers|December 19, 2012
MicroRNA in non-melanoma skin cancerMichael Sand, Daniel Sand, Peter Altmeyer, et al.
Journal of the American Academy of Dermatology|September 28, 2015
Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)Schapoor Hessam, Michael Sand, Thilo Gambichler, et al.
European Journal of Dermatology : EJD|January 7, 2020
High-dosage ustekinumab for the treatment of severe hidradenitis suppurativaLisa Scholl, Schapoor Hessam, Simone Garcovich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2024
Secukinumab is effective in a patient on haemodialysis for end-stage renal disease and severe hidradenitis suppurativaNessr Abu Rached, Lennart Ocker, Eggert Stockfleth, et al.
Journal of the American Academy of Dermatology|June 29, 2026
Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'Nessr Abu Rached, Jana Herbst, Eggert Stockfleth, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Presuturing: A simple technique for excision of large skin lesionsKonstantinos Valavanis, Schapoor Hessam, Nina Meier, et al.
Skin Pharmacology and Physiology|June 29, 2016
Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa LesionsSchapoor Hessam, Michael Sand, Dimitrios Georgas, et al.
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Archives of Dermatological Research|June 22, 2017
The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesionsS Hessam, M Sand, M Skrygan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 19, 2013
Penetrating defect of the ala nasi: combined reconstruction with a myocutaneous hinge- and paramedian forehead flapSchapoor Hessam, Dimitrios Georgas, Michael Sand, et al.
Dermatology and Therapy|January 10, 2023
Hyperhidrosis: A Central Nervous Dysfunction of Sweat SecretionJohannes Wohlrab, Falk G Bechara, Christoph Schick, et al.
Cancer Biomarkers : Section a of Disease Markers|December 19, 2012
MicroRNA in non-melanoma skin cancerMichael Sand, Daniel Sand, Peter Altmeyer, et al.
Journal of the American Academy of Dermatology|September 28, 2015
Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)Schapoor Hessam, Michael Sand, Thilo Gambichler, et al.
European Journal of Dermatology : EJD|January 7, 2020
High-dosage ustekinumab for the treatment of severe hidradenitis suppurativaLisa Scholl, Schapoor Hessam, Simone Garcovich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2024
Secukinumab is effective in a patient on haemodialysis for end-stage renal disease and severe hidradenitis suppurativaNessr Abu Rached, Lennart Ocker, Eggert Stockfleth, et al.
Journal of the American Academy of Dermatology|June 29, 2026
Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'Nessr Abu Rached, Jana Herbst, Eggert Stockfleth, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Presuturing: A simple technique for excision of large skin lesionsKonstantinos Valavanis, Schapoor Hessam, Nina Meier, et al.
Skin Pharmacology and Physiology|June 29, 2016
Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa LesionsSchapoor Hessam, Michael Sand, Dimitrios Georgas, et al.
Pageof 19